chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: U
Vaccine: COVID19
Symptoms: Body temperature, Chills, Diarrhoea, Gastrointestinal pain, Headache
Clinical narrative: diarrhea; colon spasms; extreme headaches; Fever 104 F; chill; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult patient received BNT162b2 (BNT162B2), on 13May2021 at 15:00 as dose 1, single (Lot number: FL0182), in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "extreme pain" (unspecified if ongoing); "(headache) increase" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN oral taken for pain, headache. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; GASTROINTESTINAL PAIN (non-serious), outcome "unknown", described as "colon spasms"; HEADACHE (non-serious), outcome "unknown", described as "extreme headaches"; PYREXIA (non-serious), outcome "unknown", described as "Fever 104 F"; CHILLS (non-serious), outcome "unknown", described as "chill". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The vaccine was administered in the left shoulder. Patient age at time of vaccination was 27- 28 years (as reported). For 1st/2nd dose, both caused diarrhea, colon spasms, extreme headaches, fever 104 F, chills (some patient thought were standard). Patient's father thought this was all some big government conspiracy, which was obviously silly. Patient did think that may be it was rushed out, but it was necessary. This thing saved millions of lives. Patient just wish it didn't mess up theirs (more than it already was).; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300132673 same reporter/patient/suspect drug, different dose number/event;US-PFIZER INC-202300085419 same reporter/patient/suspect drug, different dose number/event;
Sex: U
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: diarrhea; colon spasms; extreme headaches; Fever 104 F; chill; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  An adult patient received BNT162b2 (BNT162B2), on 13May2021 at 15:00 as dose 1, single (Lot number: FL0182), in left deltoid for covid-19 immunisation. The patient's relevant medical history included: "extreme pain" (unspecified if ongoing); "(headache) increase" (unspecified if ongoing). Concomitant medication(s) included: IBUPROFEN oral taken for pain, headache. The following information was reported: DIARRHOEA (non-serious), outcome "unknown", described as "diarrhea"; GASTROINTESTINAL PAIN (non-serious), outcome "unknown", described as "colon spasms"; HEADACHE (non-serious), outcome "unknown", described as "extreme headaches"; PYREXIA (non-serious), outcome "unknown", described as "Fever 104 F"; CHILLS (non-serious), outcome "unknown", described as "chill". Relevant laboratory tests and procedures are available in the appropriate section. Additional information: The vaccine was administered in the left shoulder. Patient age at time of vaccination was 27- 28 years (as reported). For 1st/2nd dose, both caused diarrhea, colon spasms, extreme headaches, fever 104 F, chills (some patient thought were standard). Patient's father thought this was all some big government conspiracy, which was obviously silly. Patient did think that may be it was rushed out, but it was necessary. This thing saved millions of lives. Patient just wish it didn't mess up theirs (more than it already was).; Sender's Comments: Linked Report(s) : US-PFIZER INC-202300132673 same reporter/patient/suspect drug, different dose number/event;US-PFIZER INC-202300085419 same reporter/patient/suspect drug, different dose number/event;
Sex: U
Vaccine: DT
Symptoms: Headache, Malaise, Pyrexia
Clinical narrative: headache; fever; malaise; Initial information received on 21-Mar-2023 regarding an unsolicited valid non-serious case received from a healthcare professional.  This case involves Infant and unknown gender patient who experienced headache, fever and malaise after receiving vaccine DIPHTHERIA AND TETANUS TOXOIDS (DT vax).  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On an unknown date, the patient received suspect DIPHTHERIA AND TETANUS TOXOIDS produced by unknown manufacturer (dose, strength, formulation, lot number and expiry date: not reported) via intramuscular route in unknown administration site for Vaccination schedule (Immunisation).  On an unknown date, the patient developed non-serious events of headache, fever (pyrexia), malaise (unknown latency) following the administration of DIPHTHERIA AND TETANUS TOXOIDS.  It is unknown if the patient experienced any additional symptoms/events. It is unknown if the patient had any medical history, concomitant disease or risk factor. It is unknown if there were lab data/results available.   Action taken with DIPHTHERIA AND TETANUS TOXOIDS was not applicable.  It was not reported if the patient received a corrective treatment for the events (headache, fever, malaise).  At time of reporting, the outcome was Recovered / Resolved on an unknown date for the event headache, was Unknown for rest of the events.
Age: 59.0
Sex: F
Vaccine: TDAP
Symptoms: Medication error, No adverse event, Poor quality product administered
Clinical narrative: she received an injection that was definitely brown with no reported adverse event; Initial information received on 22-Mar-2023 regarding an unsolicited valid  non-serious case received from a consumer/non-hcp (Non-healthcare professional).  This case involves a 59 years old female patient who reported that she received Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine [Adacel] that was definitely brown with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine Suspension for injection (with an unknown strength, batch number and expiry date) via unknown route in the left arm for Immunisation.  On an unknown date, the patient received an Diphtheria-2/Tetanus/5 Ac Pertussis Vaccine injection that was definitely brown with no reported adverse event (poor quality product administered) (latency: same day).  It was reported, Caller would like to confirm appearance of ADACEL. she said she yesterday she received an injection that was definitely brown. Spoke with consumer who wants to know what color the product is supposed to be. Says she is waiting for a call from the physician and may need to hang up. Says the product was administered yesterday in the left arm and she was provided ADACEL as the product name. She received no other vaccines the same day and is not pregnant. She had to go and had no further time. Described color of the vaccine to her. Says it was definitely brown. Informed caller the Adacel is a white cloudy suspension and should not be injected if any other color.   Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 5.0
Sex: F
Vaccine: DTAPIPV, IPV
Symptoms: Extra dose administered, No adverse event
Clinical narrative: giving two IPOL doses with no adverse event; Initial information received on 22-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 5 years old female patient who received two ipol doses (IPV (vero) [Ipol] and diphtheria-15/tetanus/5 HYBRID AC pertussis/IPV (MRC5) vaccine[Quadracel]) with no adverse event.  The patient's past medical history, medical treatment(s), concomitant medication(s), vaccination(s) and family history were not provided.   On 22-Mar-2023, the patient received 0.5 ml (dose 4) of suspect IPV (VERO) (frequency- once, strength- standard, lot number and expiry date - not reported) via intramuscular route in the left gluteus medius and 0.5 ml of (dose 5) of suspect diphtheria-15/tetanus/5 HYBRID AC pertussis/IPV (MRC5) vaccine (frequency - once, strength - standard, lot C5970AA via intramuscular route in the left deltoid for prophylactic vaccination (immunization).  On 22-Mar-2023 the patient received two ipol doses with no adverse event (extra dose administered) (latency: same day)  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  US-SA-2023SA093619:linked report
Age: 3.0
Sex: F
Vaccine: DTAPIPV
Symptoms: No adverse event, Product administered to patient of inappropriate age
Clinical narrative: QUADRACEL vaccine was administered to a child under the age of 4 with no reported adverse event; Initial information received on 23-Mar-2023 regarding an unsolicited valid  non-serious case received from a physician.  This case involves a 3 years old female patient and reporter reported Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine [Quadracel] was administered to a child under the age of 4 with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included Hepatitis A Vaccine Inact (Havrix).  On 23-Feb-2023, the patient received 0.5 ml Total (1X) of suspect Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine Suspension for injection (Frequency - once) (Strength: Standard) (lot number: C5970AA; Expiry date: 02-FEB-2024) via intramuscular route in the left thigh for Immunisation.  On 23-Feb-2023, the reporter reported Diphtheria-15/Tetanus/5 Hybrid Ac Pertussis/Ipv (Mrc5) Vaccine was administered to a child under the age of 4 with no reported adverse event (product administered to patient of inappropriate age) (Latency: same day).  It was reported, Caller states that she was waiting for a callback but she hasn't received it yet. Caller warm transferred. Physician reporting that QUADRACEL vaccine was administered to a child under the age of 4. She is inquiring if the dose can be counted as valid. This situation is reported as a medication error due to the vaccine administered to a child under the appropriate age.  Action taken: not applicable.  Outcome: Unknown   This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Sex: U
Vaccine: RAB
Symptoms: Inappropriate schedule of product administration, Medication error, No adverse event
Clinical narrative: The first dose was due on 7mar2023 and it has been 16 days out with no reportd adverse event; Initial information received on 23-Mar-2023 regarding an unsolicited valid non-serious case received from a pharmacist.  This case involves an unknown age and gender patient whose first dose of rabies (HDC) vaccine [Imovax Rabies]  was due on 7mar2023 and it has been 16 days out with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitants(s) and family history were not provided.  On an unknown date, patient received an unknown dose of suspect rabies (HDC) vaccine, powder and solvent for suspension for injection (With unknown strength, route, lot number, expiration and at unknown administration site) for prophylactic vaccination (immunization).  On an unknown date, reporter reported that patient whose first dose was due on 7mar2023 and it has been 16 days out with no reported adverse event (inappropriate schedule of product administration) (unknown latency).  No lab data were reported.  Action taken: not applicable.  At time of reporting, the outcome was Unknown for an event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 5.0
Sex: F
Vaccine: FLU4
Symptoms: No adverse event, Product storage error
Clinical narrative: during lunchtime were exposed to 15.8F for 30 minutes with no reported adverse event; FLUZONE was administered to two patients with no reported adverse event; Initial information was received on 23-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves 5 years old female patient who experienced during lunchtime were exposed to 15.8f for 30 minutes with no reported adverse event and fluzone was administered to two patients with no reported adverse event while receiving vaccine influenza quadrival a-b vaccine [Fluzone QIV].  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  On 17-Mar-2023, the patient received a 0.5 ml of  dose 1 of suspect influenza quadrival a-b vaccine lot UT7683NA expiry date: 30-JUN-2023 via intramuscular route in the deltoid not otherwise specified  for Immunization.  On 17-Mar-2023 the patient developed a non-serious event of during lunchtime were exposed to 15.8f for 30 minutes with no reported adverse event (product storage error) following the administration of influenza quadrival a-b vaccine.  On 17-MAR-2023 the patient developed a non-serious event of fluzone was administered to two patients with no reported adverse event (poor quality product administered) (unknown latency) following the administration of influenza quadrival a-b vaccine.  Action taken with QUADRIVALENT influenza vaccine (Fluzone QIV) was not applicable.  It was not reported if the patient received a corrective treatment for the events (during lunchtime were exposed to 15.8F for 30 minutes with no reported adverse event, Fluzone was administered to two patients with no reported adverse event).  At time of reporting, the outcome was Unknown for the event during lunchtime were exposed to 15.8f for 30 minutes with no reported adverse event and was Unknown for the event fluzone was administered to two patients with no reported adverse event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the Directive 2001/83/EC and Module VI of the Good Pharmacovigilance Practices. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 3.0
Sex: M
Vaccine: FLU4
Symptoms: Medication error, No adverse event, Poor quality product administered, Product storage error
Clinical narrative: FLUZONE was administered to two patients, with no reported adverse event; exposed to 15.8F for 30 minutes, with no reported adverse event; Initial information received on 23-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 3 years old male patient and it was reported influenza quadrival A-B vaccine [Fluzone quadrivalent] was exposed to 15.8f for 30 minutes and fluzone was administered to two patients, with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s), concomitants and family history were not provided.  On 01-Mar-2023, influenza quadrival A-B vaccine [Fluzone quadrivalent] suspension for injection (batch/lot number: UT7683NA and expiry date: 30-Jun-2023; Strength = standard; Frequency once) exposed to 15.8f for 30 minutes, with no reported adverse event (product storage error) (latency: unknown).  On 17-Mar-2023, 0.5 mL of suspect influenza quadrival A-B vaccine [Fluzone quadrivalent] was administered to two patients via intramuscular route in the deltoid NOS for immunization (poor quality product administered) (latency: same day).  Action taken: Not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.; Sender's Comments:  01545413: 01545335:
Age: 8.0
Sex: F
Vaccine: DTAP
Symptoms: Incomplete course of vaccination, No adverse event
Clinical narrative: received four doses of dtap as an infant, but hasn't had anything since, with no reported adverse event; Initial information received on 24-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 8 years old female patient who received four doses of dtap (diphtheria-15/tetanus/5 ac pertussis vaccine [Daptacel]) as an infant, but hasn't had anything since, with no reported adverse event   The patient's past medical history, medical treatment(s), vaccination(s), concomitants and family history were not provided.   It was reported, the patient received four doses (4 DF) of dtap (diphtheria-15/tetanus/5 ac pertussis vaccine [Daptacel]) suspension for injection as an infant (batch/lot number, expiry date, strength, dose and route: not reported for all doses) in unknown administration site for immunization, but hasn't had anything since, with no reported adverse event (incomplete course of vaccination) (unknown latency).  Action taken: Not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 1.58
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: No adverse event, Single component of a two-component product administered
Clinical narrative: Patient accidentally received a PENTACEL vaccine with only the diluent DTAP/IPV portion and not the HIB powder component with no reported adverse event; Initial information received on 27-Mar-2023 regarding an unsolicited valid non-serious case received from a other health professional.  This case involves a 19 months old male patient who accidentally received a diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine [Pentacel] vaccine with only the diluent dtap/ipv portion and not the hib powder component with no reported adverse event.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.  Concomitant medications included pneumococcal vaccine CONJ 13V (CRM197) (PREVNAR 13) for Immunisation; and hepatitis A vaccine (Hepatitis A) for Immunisation.  On 09-Mar-2023, the patient received a 0.5 ml (dose 4) of suspect diphtheria/tetanus/5 hybrid AC pertussis/IPV(MRC5)/HIB(PRP/T) vaccine, Suspension for injection (frequency - once, strength - standard, lot UJ736AAA, expiry date - 18-Sep-2023) via intramuscular route in the upper right thigh for Immunisation.  On 09-Mar-2023 the patient accidentally received a pentacel vaccine with only the diluent dtap/ipv portion and not the hib powder component with no reported adverse event (single component of a two-component product administered) (latency: same day)  Action taken: not applicable.  At time of reporting, the outcome was Unknown for the event.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out in the guidelines. The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
Age: 88.0
Sex: F
Vaccine: PNC20
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Site: Redness at Injection Site-Mild, Site: Swelling at Injection Site-Mild
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Adverse event, Arthralgia, Chills, Dehydration, Fatigue
Clinical narrative: Adverse affects to second dose of Shingrix vaccine. About six hours after dosage., sudden onset of chills. About 12 hours after. Sudden leg cramping and overactive kidneys. Peeing out at least double the fluid intake for next 12 hour's resulting in partial dehydration. Pee was clear the entire time. Severe headache and slight fever not controlled by OTC medication. Also fatigue and decrease in balance. Finally, moderate hip & pelvis aching with painful & swollen lymph nodes inside thighs at groin. This started at six hour mark and dissipated suddenly, along with peeing at about 30 hour point. At forty hours. Now have just slight fatigue and hip discomfort
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Headache, Lymphadenopathy, Muscle spasms, Musculoskeletal discomfort, Pelvic pain
Clinical narrative: Adverse affects to second dose of Shingrix vaccine. About six hours after dosage., sudden onset of chills. About 12 hours after. Sudden leg cramping and overactive kidneys. Peeing out at least double the fluid intake for next 12 hour's resulting in partial dehydration. Pee was clear the entire time. Severe headache and slight fever not controlled by OTC medication. Also fatigue and decrease in balance. Finally, moderate hip & pelvis aching with painful & swollen lymph nodes inside thighs at groin. This started at six hour mark and dissipated suddenly, along with peeing at about 30 hour point. At forty hours. Now have just slight fatigue and hip discomfort
Age: 54.0
Sex: M
Vaccine: VARZOS
Symptoms: Pyrexia, Renal impairment, Urine output increased
Clinical narrative: Adverse affects to second dose of Shingrix vaccine. About six hours after dosage., sudden onset of chills. About 12 hours after. Sudden leg cramping and overactive kidneys. Peeing out at least double the fluid intake for next 12 hour's resulting in partial dehydration. Pee was clear the entire time. Severe headache and slight fever not controlled by OTC medication. Also fatigue and decrease in balance. Finally, moderate hip & pelvis aching with painful & swollen lymph nodes inside thighs at groin. This started at six hour mark and dissipated suddenly, along with peeing at about 30 hour point. At forty hours. Now have just slight fatigue and hip discomfort
Sex: M
Vaccine: COVID19-2
Symptoms: Myalgia, Polymyalgia rheumatica, Red blood cell sedimentation rate abnormal
Clinical narrative: I was administered the 5 Moderna Covid Vaccines. The bivariant was administered on 10/26/2022. Soon after I began experiencing severe muscle soreness in my hips and shoulders. On 12/20/2022 Dr. examined me and she gave me a preliminary diagnosis of polymyalgia rheumatica (PMR). Dr. gave me a script for 15 mgs of prednisone. Dr telephoned the following morning and I was 80% better. This confirmed the PMR diagnosis I visited rheumatologist Dr and I am not on a prednisone tapering program for 12 months SED rate confirmed infection.
Age: 64.0
Sex: U
Vaccine: VARZOS
Symptoms: Erythema, Pruritus, Tenderness
Clinical narrative: I received the second Shingrix vaccine on 3/15/23 in my left deltoid. The following day I had redness the size of the palm of my hand under my deltoid. There was also extreme tenderness. The redness continued for 3-4 days. On the 3rd day I started to also experience itching in this area. I used Benadryl ointment on the area and took Advil. Everything was resolved on day 5.
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Respiratory symptom, SARS-CoV-2 test positive
Clinical narrative: I tested positive for Covid 19 on 3/18 and completed a 5 day course of Lagevrio (because I am on Eliquis). I was symptom free days 5-7 but developed mild URI symptoms on day 8. I restarted my 5 day isolation. I was told I likely had a rebound case of Covid. I have received 5 Covid vaccine doses, the bivalent in September 2022. (Had my immunity waned?) This is my first case of Covid 19 after being very careful for three years. When symptoms abated, I did daily rapid antigen tests but remained very faintly positive so isolation continued. Now on day 11 I am waiting to retest when symptoms are gone and I end my isolation.
Age: 91.0
Sex: F
Vaccine: PPV
Symptoms: Autoimmune disorder, Brachial plexopathy, Gait inability, Muscular weakness, Pain in extremity
Clinical narrative: Patient reported to have received Pneumovax -23 vaccine on 3/16/2023, administered to right upper extremity. Patient developed pain to right upper extremity along with weakness which spread to the lower legs. Patient was unable to walk, where as, prior to vaccination she was able to walk with a walker. Weakness is described as bilateral but predominantly to right side/Right lower extremity. No fever, no rash reported. Patient diagnosed with autoimmune brachial plexopathy.
Age: 23.0
Sex: F
Vaccine: HEPAB
Symptoms: Dizziness, Loss of consciousness, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: pt was light headed after injection.  Pt passed out/lost consciousness for approx 20 sec.  Recovered completely after approx. 5 minutes.  Left store with grandparent afterwards.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Amnesia, Confusional state, Memory impairment, Speech disorder
Clinical narrative: Systemic: Confusion-Severe, Systemic: Progressive short term memory loss-Severe, Additional Details: Patient reports losing memory slowly over the last year, it is getting progessively worse. She may have a day where she can't get out of bed due to the confusion. Has a hard time having a conversation with husband, mostly short term memory. Has spoken to other people and the same thing seems to have happened to them. Seems to be directly related to after vaccine.
Age: 58.0
Sex: M
Vaccine: COVID19
Symptoms: Asthma, Eosinophil count increased
Clinical narrative: I developed eosinophilic asthma at some point after the first vaccine and the booster.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Headache, Nasal congestion, Pyrexia, Respiratory tract congestion
Clinical narrative: I experienced a breakthrough case of COVID-19 with a stuffy nose, head congestion, fever, sneezing, headaches.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Sneezing, Vaccine breakthrough infection
Clinical narrative: I experienced a breakthrough case of COVID-19 with a stuffy nose, head congestion, fever, sneezing, headaches.
Age: 81.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Nasopharyngitis, Rhinorrhoea, SARS-CoV-2 test positive
Clinical narrative: 1/27/2023   I thought I had a cold, which I don?t normally get. During the night, my nose was runny. The next day I did an at home COVID test and it was positive. I had a telehealth visit with the nurse.  I was prescribed Paxlovid which I started taking that night, 1/28/23.  It seemed to help,I got over it really quickly. I took the Paxlovid for 5 days.
Age: 78.0
Sex: M
Vaccine: COVID19-2
Symptoms: Bronchitis, Chest X-ray abnormal, Cough, Dysphonia
Clinical narrative: I woke up feeling a lot of coughing and that coughing got heavier and more intense and lasted for over month. I went to see my PCP for help and steroids were issued and a chest x-ray was done. After medicine I went back because nothing was better. So I went to an ENT specialist because nothing was better. I had a terrible cough that produced nothing. The ENT said I was taking all the wrong medicines for the hoarseness. The ENT put me on nasal administered medicine, FLONASE. He detected resurgence at night. Famotidine. I will see my ENT again on 05APR20233 and 15MAY2023.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Fatigue, Pain in extremity, Respiratory tract congestion, SARS-CoV-2 test positive
Clinical narrative: I felt fatigued and my arm was achy for about a day. I had congestion and sneezing on 03/23/2023. I tested positive for COVID-19 on 03/24/2023. I contacted my doctor and got a prescription for PAXLOVID but I did not take as I was feeling better. I am feeling better with no lingering symptoms.
Age: 62.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sneezing
Clinical narrative: I felt fatigued and my arm was achy for about a day. I had congestion and sneezing on 03/23/2023. I tested positive for COVID-19 on 03/24/2023. I contacted my doctor and got a prescription for PAXLOVID but I did not take as I was feeling better. I am feeling better with no lingering symptoms.
Age: 2.0
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Injection site erythema, Injection site induration
Clinical narrative: More than a 2 inch in diameter red, hardened circle/rashing around the injection site
Age: 1.42
Sex: M
Vaccine: COVID19-2
Symptoms: Decreased appetite, Hand-foot-and-mouth disease, Lethargy, Pyrexia, Respiratory syncytial virus infection
Clinical narrative: On 3/6/23 he woke up with a fever and was lethargic. He also had a reduced appetite. We took him to urgent care, and they ran a COVID-19 test and RSV test. He tested positive for RSV. We gave him TYLENOL and MOTRIN. No other medications were prescribed. The RSV was resolved in about two days. Then he woke up with a fever again on 3/28/23. He was also lethargic, and no appetite. We took him to the doctor, and he was diagnosed with hands foot mouth. Today his fever is lower but still there. We are giving him MOTRIN and TYLENOL. He has some sores in his mouth, but none on his hands and feet yet. The doctor said that he probably will though.
Age: 1.42
Sex: M
Vaccine: COVID19-2
Symptoms: Respiratory syncytial virus test positive, SARS-CoV-2 test negative, Stomatitis
Clinical narrative: On 3/6/23 he woke up with a fever and was lethargic. He also had a reduced appetite. We took him to urgent care, and they ran a COVID-19 test and RSV test. He tested positive for RSV. We gave him TYLENOL and MOTRIN. No other medications were prescribed. The RSV was resolved in about two days. Then he woke up with a fever again on 3/28/23. He was also lethargic, and no appetite. We took him to the doctor, and he was diagnosed with hands foot mouth. Today his fever is lower but still there. We are giving him MOTRIN and TYLENOL. He has some sores in his mouth, but none on his hands and feet yet. The doctor said that he probably will though.
Age: 1.0
Sex: M
Vaccine: VARCEL
Symptoms: Skin lesion, Vaccination site reaction
Clinical narrative: Patient reacted with localized chicken pox like lesions around vaccine site
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: COVID-19, Cough, Malaise, Nasopharyngitis, Respiratory disorder
Clinical narrative: I did not have an adverse reaction to the vaccine. I began not feeling well on 02/17/2023 with cold like symptoms. I tested positive for COVID-19 on 02/19/2023. I contacted an urgent care to get the prescription PAXLOVID but did not take. I only took TYLENOL to help with my symptoms. As of today, I have a cough and I feel like I get respiratory illnesses easier.
Age: 67.0
Sex: F
Vaccine: COVID19-2, FLUX
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I did not have an adverse reaction to the vaccine. I began not feeling well on 02/17/2023 with cold like symptoms. I tested positive for COVID-19 on 02/19/2023. I contacted an urgent care to get the prescription PAXLOVID but did not take. I only took TYLENOL to help with my symptoms. As of today, I have a cough and I feel like I get respiratory illnesses easier.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Blood test normal, COVID-19, Cough, Fatigue, Respiratory tract congestion
Clinical narrative: 3/6/2023 I woke up with a scratchy throat and sneezing. I felt it was maybe allergies. No other symptoms. The next day, the same thing. On 3/8/23 I woke up congested, runny nose and a tickle, not a bad cough. I was more tired than normal. I took an at home COVID test which was positive. I had a telehealth visit that day and was prescribed PAXLOVID after having bloodwork. On 3/9/23 I began taking PAXLOVID. By that time, I had a bad runny nose, sneezing a lot, the cough was worse and I was really tired. By 3/10/23 I noticed an improvement in the symptoms. I took the PAXLOVID for 5 days and my symptoms never progressed into anything worse.
Age: 65.0
Sex: F
Vaccine: COVID19-2
Symptoms: Rhinorrhoea, SARS-CoV-2 test positive, Sneezing, Throat irritation
Clinical narrative: 3/6/2023 I woke up with a scratchy throat and sneezing. I felt it was maybe allergies. No other symptoms. The next day, the same thing. On 3/8/23 I woke up congested, runny nose and a tickle, not a bad cough. I was more tired than normal. I took an at home COVID test which was positive. I had a telehealth visit that day and was prescribed PAXLOVID after having bloodwork. On 3/9/23 I began taking PAXLOVID. By that time, I had a bad runny nose, sneezing a lot, the cough was worse and I was really tired. By 3/10/23 I noticed an improvement in the symptoms. I took the PAXLOVID for 5 days and my symptoms never progressed into anything worse.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain upper, Alanine aminotransferase increased, Anal incontinence, Aspartate aminotransferase increased, Back pain
Clinical narrative: I had right upper quadrant pain radiating in my back. I was fairly severe. I went to the emergency room on January 31, 2021. They did an ultrasound and a Cat scan, and they diagnosed me with kidney cancer. I had to follow up with a urologist. I saw him on March 08, 2021, and had surgery around March 15, 2021, for a partial removal of the vaccine. I remained hospitalized for 1 day. I did not need to have any chemo or radiation. I was advised to follow up.  I am still having pain. Since October 2022 I have had uncontrollable stool and at times diarrhea. I have taken antibiotics and taken Imodium to slow the process. I had bloodwork done last Wednesday and I have an ultrasound scheduled for next week. The bloodwork indicated that my liver enzymes were elevated. I do not believe it is related to COVID-19 vaccination, but I wanted to report as I am questioning whether it is a gall bladder issue related to the vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Benign neoplasm of thyroid gland, Blood alkaline phosphatase increased, Blood test abnormal, Computerised tomogram abnormal, Diarrhoea
Clinical narrative: I had right upper quadrant pain radiating in my back. I was fairly severe. I went to the emergency room on January 31, 2021. They did an ultrasound and a Cat scan, and they diagnosed me with kidney cancer. I had to follow up with a urologist. I saw him on March 08, 2021, and had surgery around March 15, 2021, for a partial removal of the vaccine. I remained hospitalized for 1 day. I did not need to have any chemo or radiation. I was advised to follow up.  I am still having pain. Since October 2022 I have had uncontrollable stool and at times diarrhea. I have taken antibiotics and taken Imodium to slow the process. I had bloodwork done last Wednesday and I have an ultrasound scheduled for next week. The bloodwork indicated that my liver enzymes were elevated. I do not believe it is related to COVID-19 vaccination, but I wanted to report as I am questioning whether it is a gall bladder issue related to the vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Hepatic enzyme increased, Nodule, Pain, Renal cancer, Surgery
Clinical narrative: I had right upper quadrant pain radiating in my back. I was fairly severe. I went to the emergency room on January 31, 2021. They did an ultrasound and a Cat scan, and they diagnosed me with kidney cancer. I had to follow up with a urologist. I saw him on March 08, 2021, and had surgery around March 15, 2021, for a partial removal of the vaccine. I remained hospitalized for 1 day. I did not need to have any chemo or radiation. I was advised to follow up.  I am still having pain. Since October 2022 I have had uncontrollable stool and at times diarrhea. I have taken antibiotics and taken Imodium to slow the process. I had bloodwork done last Wednesday and I have an ultrasound scheduled for next week. The bloodwork indicated that my liver enzymes were elevated. I do not believe it is related to COVID-19 vaccination, but I wanted to report as I am questioning whether it is a gall bladder issue related to the vaccine.
Age: 59.0
Sex: F
Vaccine: COVID19
Symptoms: Ultrasound scan abnormal, Ultrasound thyroid abnormal
Clinical narrative: I had right upper quadrant pain radiating in my back. I was fairly severe. I went to the emergency room on January 31, 2021. They did an ultrasound and a Cat scan, and they diagnosed me with kidney cancer. I had to follow up with a urologist. I saw him on March 08, 2021, and had surgery around March 15, 2021, for a partial removal of the vaccine. I remained hospitalized for 1 day. I did not need to have any chemo or radiation. I was advised to follow up.  I am still having pain. Since October 2022 I have had uncontrollable stool and at times diarrhea. I have taken antibiotics and taken Imodium to slow the process. I had bloodwork done last Wednesday and I have an ultrasound scheduled for next week. The bloodwork indicated that my liver enzymes were elevated. I do not believe it is related to COVID-19 vaccination, but I wanted to report as I am questioning whether it is a gall bladder issue related to the vaccine.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Bronchitis, COVID-19, Chills, Cough, Dyspnoea
Clinical narrative: 3/22/2023 in the evening I noticed chills, shortness of breath, cough, and fever of 99. Felt like I was coming down with bronchitis. The next day, 3/23 symptoms got worse, fatigue developed and cough deepened. Tested with an at home COVID-19 test, positive. Televisit with doctor. Doctor proscribed PAXLOVID and to treat symptomatically. Started PAXLOVID that day. Symptoms stayed the same for about 4 days. Started to feel better on 3/27 and things gradually got better but fatigue and cough linger to time of reporting.
Age: 58.0
Sex: F
Vaccine: COVID19-2
Symptoms: Fatigue, Pyrexia, SARS-CoV-2 test positive
Clinical narrative: 3/22/2023 in the evening I noticed chills, shortness of breath, cough, and fever of 99. Felt like I was coming down with bronchitis. The next day, 3/23 symptoms got worse, fatigue developed and cough deepened. Tested with an at home COVID-19 test, positive. Televisit with doctor. Doctor proscribed PAXLOVID and to treat symptomatically. Started PAXLOVID that day. Symptoms stayed the same for about 4 days. Started to feel better on 3/27 and things gradually got better but fatigue and cough linger to time of reporting.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Cough, Oropharyngeal pain, Pain, Respiratory tract congestion
Clinical narrative: I had a very sore throat, and unusual sneeze and a cough. I also had congestion and body aches.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: SARS-CoV-2 test positive, Sneezing
Clinical narrative: I had a very sore throat, and unusual sneeze and a cough. I also had congestion and body aches.
Age: 66.0
Sex: F
Vaccine: COVID19-2
Symptoms: Abdominal pain
Clinical narrative: 1/4/2023 I had severe abdominal pain. I waited it out because I had to go to the bathroom a lot and did not feel like moving. I took diacylamine and used a heating pad. I have had this before, but this was more severe. The event lasted about four hours, but continued like someone punched me in the stomach for a couple of days.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Influenza like illness, Malaise, Nasopharyngitis, Rhinorrhoea
Clinical narrative: My COVID-19 symptoms started on 02/15/2023. I had a bad cold. I felt like it was a flu. I also had a very runny nose. On 02/19/2023 I did a home test which was positive. On 02/20/2023 I walked in at my doctor's office. My doctor prescribed me PAXLOVID for 5 days. I did 3 tests on the following Friday on 02/25/2023 which were all negative.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: My COVID-19 symptoms started on 02/15/2023. I had a bad cold. I felt like it was a flu. I also had a very runny nose. On 02/19/2023 I did a home test which was positive. On 02/20/2023 I walked in at my doctor's office. My doctor prescribed me PAXLOVID for 5 days. I did 3 tests on the following Friday on 02/25/2023 which were all negative.
Age: 75.0
Sex: F
Vaccine: COVID19
Symptoms: Atrial fibrillation, Cardioversion, Condition aggravated, Pain in extremity
Clinical narrative: I had a sore arm after the vaccine for a day. I have had AFIB for four years, but it got worse 11/2022. I went to the emergency room and was admitted for three days and had the cardioversion. Since then, I had two more cardioversion procedures. I am waiting for cardiac ablation in May 2023.
Age: 61.0
Sex: F
Vaccine: COVID19-2
Symptoms: COVID-19, Ear pain, Fatigue, Headache, SARS-CoV-2 test positive
Clinical narrative: I had a headache, left ear hurt, I never had a fever, I used a home COVID-19 test that came back positive, I called my doctor let her know. She prescribed the PAXLOVID, that I was able to start the next. I started to feel better two days later, I did have fatigue, but I was feeling better. Within two days I started testing negative and was never positive again. I attribute this to my having all the vaccines.
Age: 43.0
Sex: M
Vaccine: COVID19-2
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Client was inadvertently given a booster too early.  His second dose in the primary series was given 3/3/2023, his booster was given 3/28/2023.  Dr. was notified, as well as nursing staff, LPN at Center.  LPN was asked to notify the client and to reach out to me with any concerns or if the client had any problems for follow up with our physician.
Age: 73.0
Sex: M
Vaccine: COVID19-2
Symptoms: Nasopharyngitis, Secretion discharge, Sinusitis
Clinical narrative: No serious symptoms after the vaccine, early this month I had a cold, it got worst, and I had a mucus and called my doctor, and he said I have sinus infection and gave me some antibiotics.
Age: 1.42
Sex: M
Vaccine: DTAPIPVHIB
Symptoms: Expired product administered, No adverse event
Clinical narrative: Patient administered expired vaccine.  No adverse outcome reported.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Feeling abnormal, Malaise, Pulmonary fibrosis, Pulmonary function test abnormal
Clinical narrative: I positive for COVID-19 on 01JUN2022, I was feeling very sick and worn over. As of 15MAR2023 I had a Pulmonary function testing and it came back positive for Fibrosis. I have upcoming doctor visits that will tell me more.
Age: 75.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive
Clinical narrative: I positive for COVID-19 on 01JUN2022, I was feeling very sick and worn over. As of 15MAR2023 I had a Pulmonary function testing and it came back positive for Fibrosis. I have upcoming doctor visits that will tell me more.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: COVID-19, Cough, Fatigue, Headache, Productive cough
Clinical narrative: The two most notable symptoms were headache and upper respiratory congestion. That lasted in the late morning of the 13th and tested around 04:00pm that afternoon. I immediately call my doctor. She prescribed an antibiotic and Paxlovid. I took my first on that same day.  The headache went away within a couple of hours. The upper respiratory cough was wet, dry and deep. It was about a week before I felt normal. I was tired a few days, but the coughing lasted about a week.
Age: 69.0
Sex: M
Vaccine: COVID19-2
Symptoms: SARS-CoV-2 test positive, Upper respiratory tract congestion
Clinical narrative: The two most notable symptoms were headache and upper respiratory congestion. That lasted in the late morning of the 13th and tested around 04:00pm that afternoon. I immediately call my doctor. She prescribed an antibiotic and Paxlovid. I took my first on that same day.  The headache went away within a couple of hours. The upper respiratory cough was wet, dry and deep. It was about a week before I felt normal. I was tired a few days, but the coughing lasted about a week.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Dyspnoea, Feeling abnormal, Malaise, Night sweats, Sinus congestion
Clinical narrative: 1/2/2023  I started out not feeling well. It progressed to night sweats. This lasted for about a week. The second week of January, I started feeling bad, but nothing I could put my finger on.  I was down with clogged sinuses and night sweats. I was not eating, I lost around 5 or 6 pounds. I started taking Flonase but stopped because it made it worse.  The third week, I started feeling a little better, just mainly sinuses. The fourth week, it really got bad. It was mainly clogged sinuses, I had to breath out of my mouth.  My son said I was having labored breathing. I had a telehealth visit and he prescribed a Z Pak and Prednisone. I did not take the Prednisone.    It took another three days to actually blow the congestion out of my nose. This went on for three or four days. It finally cleared up.  I was literally down for the month of January.
Age: 67.0
Sex: F
Vaccine: COVID19-2
Symptoms: Sinusitis
Clinical narrative: 1/2/2023  I started out not feeling well. It progressed to night sweats. This lasted for about a week. The second week of January, I started feeling bad, but nothing I could put my finger on.  I was down with clogged sinuses and night sweats. I was not eating, I lost around 5 or 6 pounds. I started taking Flonase but stopped because it made it worse.  The third week, I started feeling a little better, just mainly sinuses. The fourth week, it really got bad. It was mainly clogged sinuses, I had to breath out of my mouth.  My son said I was having labored breathing. I had a telehealth visit and he prescribed a Z Pak and Prednisone. I did not take the Prednisone.    It took another three days to actually blow the congestion out of my nose. This went on for three or four days. It finally cleared up.  I was literally down for the month of January.
Age: 17.0
Sex: F
Vaccine: HPV9, IPV, MMR, VARCEL
Symptoms: Exposure during pregnancy, Pregnancy test positive, Ultrasound scan normal
Clinical narrative: Child was seen for initial Obstetrics visit onn 3/27/2023 after being referred by PCP for positive pregnancy test during initial medical exam on 3/20/2023. Sonogram performed on child noted gestational age to be 6 weeks with due date noted as 11/15/23. Child is doing well and has no complains. Child has prescribed Prenatal tablets once daily.